A prospective, observational study of the effectiveness, safety and impact on quality of life (QoL) of a weekly fixed dose of darbepoetin alfa (DA) for the treatment of chemotherapy-induced anemia (CIA) in patients (pts) with non-myeloid malignancies | Publicación